Crohn's Disease

In this Healio video series, which focuses on cultural competency in the treatment of inflammatory bowel disease, Shaji Sebastian, MD, FRCP, discusses IBD incidence in South Asian countries and advances in research and care for patients.

Earlier administration of anti-tumor necrosis factor therapy reduced health care resource utilization in patients with Crohn’s disease but not in patients with ulcerative colitis, according to research.

Endoscopic balloon dilation was more effective than fully covered self-expandable metal stents for Crohn’s disease strictures, according to a study published in The Lancet Gastroenterology & Hepatology.

In this Healio video series, which focuses on cultural competency in the treatment of inflammatory bowel disease, patient advocate Madhura Balasubramaniam shares her experience living with Crohn’s disease in India.

In patients with inflammatory bowel disease, colonoscopy within 3 years before colorectal cancer diagnosis was linked with early tumor stage detection, while colonoscopy within 1 year reduced overall all-cause mortality, according to data.

Individuals with inflammatory bowel disease are not at increased risk for severe complications from COVID-19 infection, according to data presented at the Basic and Clinical Immunology for the Busy Clinician symposium.

In this Healio video series, which focuses on cultural competency in the treatment of inflammatory bowel disease, Neilanjan Nandi, MD, FACP, discusses the importance of increasing community knowledge and destigmatizing IBD.

In this Healio video series, which focuses on cultural competency in the treatment of inflammatory bowel disease, Sharan Khela, an IBD patient advocate who has Crohn’s disease, shares her story and cultural stigmas she has had to overcome.

Long-term ustekinumab effectively and safely treated most patients in a “difficult-to-treat” Crohn’s disease cohort, according to research presented at the European Crohn’s and Colitis Organization meeting.

Tremfya effectively induced clinical and corticosteroid-free remission among patients with moderate to severe Crohn’s disease, according to a presentation at the Congress of European Crohn’s and Colitis Organization.